The Mylk3 variant associated with loss of full‐length MLCK3 is widespread in C57BL / 6N and related NIH ‐derived mouse substrains
Animal Models and Experimental Medicine · 18.11.2026
DOI: 10.1002/ame2.70326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 18.11.2026. Verfasst von Sevilay Şahoğlu Göktaş und 7 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Stiftelsen för Strategisk Forskning, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Genetic variation among C57BL/6 mouse strains may influence cardiovascular phenotypes and contribute to inter‐study variability in biomedical research. We investigated the distribution of the Mylk3 c.‐5T>A variant, previously shown to cause loss of cardiac myosin light‐chain kinase (MLCK3) and late‐onset dilated cardiomyopathy, across C57BL/6 lineages. The variant was homozygously present in C57BL/6N and C57BL/6By strains but absent from C57BL/6J‐derived mouse strains. This distribution indicates that the variant was established before divergence of the C57BL/6By branch, although its precise origin cannot be determined from contemporary samples. Despite preserved Mylk3 transcript abundance, C57BL/6N hearts lacked full‐length MLCK3 protein. These findings exemplify how genetic differences between seemingly identical wild‐type backgrounds can introduce significant confounding factors, highlighting the importance of accurate substrain identification and reporting for experimental design, interpretation, and reproducibility. Highlighting the broader relevance of these findings, a survey of 1238 recent open‐access articles from cardiovascular journals found that 35% reported the use of C57BL/6 mice without specifying the N or J substrain. Altogether, our findings identify the Mylk3 variant as a lineage‐defining feature of C57BL/6N mice and related substrains, with potential implications for cardiovascular studies using this background.
Förderung
- Vetenskapsrådet
- Stiftelsen för Strategisk Forskning
- Ministry of Education, Culture, Sports, Science and Technology
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Göktaş, S. Ş., Mekada, K., Costa, A. P. D., Velasco, R. Q. S., Duarte, J. M. N., Castilho, R. F., Meissner, A., & Francisco, A. (2026). The Mylk3 variant associated with loss of full‐length MLCK3 is widespread in C57BL / 6N and related NIH ‐derived mouse substrains. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70326
Vancouver
Göktaş SŞ, Mekada K, Costa APD, Velasco RQS, Duarte JMN, Castilho RF, et al. The Mylk3 variant associated with loss of full‐length MLCK3 is widespread in C57BL / 6N and related NIH ‐derived mouse substrains. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70326
BibTeX
@article{Gkta2026,
author = {Göktaş, Sevilay Şahoğlu and Mekada, Kazuyuki and Costa, Ana P. Dalla and Velasco, Rafaela Q. S. and Duarte, Joao M. N. and Castilho, Roger F. and Meissner, Anja and Francisco, Annelise},
title = {The Mylk3 variant associated with loss of full‐length MLCK3 is widespread in C57BL / 6N and related NIH ‐derived mouse substrains},
journal = {Animal Models and Experimental Medicine},
year = {2026},
doi = {10.1002/ame2.70326}
}
EUVIMED